SECsense Logo

Seres Therapeutics 8-K Report: Key Updates from January 9, 2025

$MCRB
Form 8-K
Filed on: 2025-01-10
Source
Seres Therapeutics 8-K Report: Key Updates from January 9, 2025

Based on the provided section of the financial report, here are the key insights and information extracted:

  1. Company Information:
  • Name: Seres Therapeutics, Inc.
  • CIK: 0001609809
  • Address: 101 Cambridgepark Drive, Cambridge, MA 02140
  • Contact Number: (617) 945-9626
  1. Filing Details:
  • Filing Type: 8-K
  • Filing Date: January 9, 2025
  • SEC File Number: 001-37465
  • IRS Employer Identification Number (EIN): 27-4326290
  1. Security Information:
  • Type of Security: Common stock
  • Par Value: $0.001 per share
  • Ticker Symbol: MCRB
  • Exchange: NASDAQ
  1. Period Information:
  • Report Period: The report covers a single day, January 9, 2025.
  1. XBRL Information:
  • The document is structured in XBRL (eXtensible Business Reporting Language), a format commonly used for SEC filings to facilitate data sharing and analysis.

Insights:

  • The filing is a Form 8-K, which is typically used to report major events that shareholders should know about. The specific nature of the event is not detailed in the provided text, but it indicates that an important update or event occurred on January 9, 2025.
  • The company is publicly traded on NASDAQ under the ticker symbol "MCRB", and it is important for investors to monitor 8-K filings for significant corporate developments.
  • The common stock has a very low par value, which is typical for many publicly traded companies and may indicate a focus on retaining flexibility in capital structure.

Overall, the extract provides fundamental information about Seres Therapeutics, Inc., its filing type, and the nature of the reported period, indicating that stakeholders should review this filing for any significant announcements.